Filing Details
- Accession Number:
- 0001415889-21-001299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:00:58
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-03 20:00:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591306 | J John Kuch | C/O Xencor, Inc. 111 W. Lemon Ave Monrovia CA 91016 | Sr. Vice President & Cfo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-01 | 15,065 | $11.05 | 101,285 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 15,065 | $48.90 | 86,220 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-03 | 805 | $45.09 | 85,415 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2021-03-01 | 15,065 | $0.00 | 15,065 | $11.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,585 | 2024-02-20 | No | 4 | M | Direct |
Footnotes
- Represents option exercise and sale pursuant to a 10b5-1 plan.
- The weighted average sale price for the transaction reported was $48.8996, and the range of prices were between $48.18 and $49.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 2,259 restricted stock units.
- The shares subject to the option were subject to a vesting schedule and became fully vested on February 21, 2018.
- The initial filing incorrectly listed the number of securities beneficially owned following the transaction as 25,065 instead of 25,650 due to a typo carried over from a prior filing. The number of securities beneficially owned following this transaction was calculated off the 25,650 figure.
Billionaire Hedge Funds
